Comparative Study of Multicellular Tumor Spheroid Formation Methods and Implications for Drug Screening.
暂无分享,去创建一个
Kelly R Stevens | Maria F. Gencoglu | Shelly R Peyton | Daniel C Corbett | K. Stevens | S. Peyton | Elizabeth A Brooks | C. Hall | Daniel C. Corbett | A. Schwartz | Alyssa D Schwartz | Lauren E Barney | Christopher L Hall | L. Barney | Maria F Gencoglu
[1] R. Bjerkvig,et al. Effects of EGF, BFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain‐tumour biopsies In Vitro , 1993, International journal of cancer.
[2] S. Beissert,et al. Development of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testing , 2013, Cell Death and Disease.
[3] Silviya P Zustiak,et al. Hydrolytically degradable poly(ethylene glycol) hydrogel scaffolds with tunable degradation and mechanical properties. , 2010, Biomacromolecules.
[4] L. weiswald,et al. Spherical Cancer Models in Tumor Biology1 , 2015, Neoplasia.
[5] L. Kunz-Schughart,et al. Multicellular tumor spheroids: an underestimated tool is catching up again. , 2010, Journal of biotechnology.
[6] S. Parsons,et al. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] M. Eberl,et al. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL , 2011, Breast Cancer Research.
[8] C. Cordon-Cardo,et al. A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.
[9] Hossein Tavana,et al. Engineered Breast Cancer Cell Spheroids Reproduce Biologic Properties of Solid Tumors , 2016, Advanced healthcare materials.
[10] J. Dopazo,et al. Mammosphere Formation in Breast Carcinoma Cell Lines Depends upon Expression of E-cadherin , 2013, PloS one.
[11] D. Wallwiener,et al. Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro investigations. , 2004, European Journal of Gynaecological Oncology.
[12] Jay C. Sy,et al. Maleimide Cross‐Linked Bioactive PEG Hydrogel Exhibits Improved Reaction Kinetics and Cross‐Linking for Cell Encapsulation and In Situ Delivery , 2012, Advanced materials.
[13] Thomas D. Schmittgen,et al. Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.
[14] B. Ducommun,et al. Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer , 2012, BMC Cancer.
[15] J. Yuhas,et al. Multicellular tumor spheroid formation by breast cancer cells isolated from different sites. , 1978, Cancer research.
[16] S. Narod. Have we given up on a cure for ovarian cancer? , 2015, Current oncology.
[17] S. Leenstra,et al. Effects of irradiation and cisplatin on human glioma spheroids: inhibition of cell proliferation and cell migration , 2005, Journal of Cancer Research and Clinical Oncology.
[18] Juergen Friedrich,et al. Experimental anti-tumor therapy in 3-D: Spheroids – old hat or new challenge? , 2007, International journal of radiation biology.
[19] James P. Freyer,et al. The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model , 2004, Journal of biomolecular screening.
[20] S. Takayama,et al. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[21] K. Cheung,et al. Droplet-based microfluidic system for multicellular tumor spheroid formation and anticancer drug testing. , 2010, Lab on a chip.
[22] A. Mes-Masson,et al. Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids , 2008, BMC Genomics.
[23] P. Sorger,et al. Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs , 2016, Nature Methods.
[24] S. Kalloger,et al. Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation , 2011, International journal of molecular sciences.
[25] M. Hung,et al. The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines , 2010 .
[26] Keiran S. M. Smalley,et al. Life ins't flat: Taking cancer biology to the next dimension , 2006, In Vitro Cellular & Developmental Biology - Animal.
[27] Liju Yang,et al. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. , 2014, Assay and drug development technologies.
[28] E. Keller,et al. Type I Collagen Receptor (α2β1) Signaling Promotes the Growth of Human Prostate Cancer Cells within the Bone , 2006 .
[29] Gordon B Mills,et al. Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells. , 2012, Cancer cell.
[30] S. Eccles,et al. Tumor spheroid-based migration assays for evaluation of therapeutic agents. , 2013, Methods in molecular biology.
[31] T. Matsushita,et al. Enhancement of drug efflux activity via MDR1 protein by spheroid culture of human hepatic cancer cells. , 2011, Journal of bioscience and bioengineering.
[32] Vladimir P Torchilin,et al. Cancer cell spheroids as a model to evaluate chemotherapy protocols , 2012, Cancer biology & therapy.
[33] Kenneth M. Yamada,et al. Modeling Tissue Morphogenesis and Cancer in 3D , 2007, Cell.
[34] Raha Abdul Rahim,et al. Development of Multicellular Tumor Spheroid (MCTS) Culture from Breast Cancer Cell and a High Throughput Screening Method Using the MTT Assay , 2012, PloS one.
[35] Shuichi Takayama,et al. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. , 2011, The Analyst.
[36] R. Sutherland,et al. Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. , 1971, Journal of the National Cancer Institute.
[37] Benjamin Haibe-Kains,et al. Inconsistency in large pharmacogenomic studies , 2013, Nature.
[38] H. Thierens,et al. Screening for supra-additive effects of cytotoxic drugs and gamma irradiation in an in vitro model for hepatocellular carcinoma. , 2004, Canadian journal of physiology and pharmacology.
[39] KR Stevens,et al. InVERT molding for scalable control of tissue microarchitecture , 2013, Nature Communications.
[40] Brendon M. Baker,et al. Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues , 2012, Journal of Cell Science.
[41] A. Shiras,et al. Differential expression of CD44(S) and variant isoforms v3, v10 in three-dimensional cultures of mouse melanoma cell lines , 2004, Clinical & Experimental Metastasis.
[42] Ying Zhang,et al. Development of an in Vitro Multicellular Tumor Spheroid Model Using Microencapsulation and Its Application in Anticancer Drug Screening and Testing , 2008, Biotechnology progress.
[43] G. Mor,et al. Apoptosis-Based Evaluation of Chemosensitivity in Ovarian Cancer Patients , 2004, The Journal of the Society for Gynecologic Investigation: JSGI.
[44] P. Zandstra,et al. Reproducible, Ultra High-Throughput Formation of Multicellular Organization from Single Cell Suspension-Derived Human Embryonic Stem Cell Aggregates , 2008, PloS one.
[45] Maria Teresa Santini,et al. Three-Dimensional Spheroid Model in Tumor Biology , 1999, Pathobiology.
[46] Brian Keith,et al. Hypoxia-Inducible Factors, Stem Cells, and Cancer , 2007, Cell.
[47] J. Jardillier,et al. Multicellular resistance: a paradigm for clinical resistance? , 2000, Critical reviews in oncology/hematology.
[48] S. Howell,et al. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases. , 2012, Neoplasia.
[49] J. Meléndez-Zajgla,et al. Transcriptome profile of the early stages of breast cancer tumoral spheroids , 2016, Scientific Reports.
[50] D. Alberts,et al. Comparative in vitro cytotoxicity of cyclophosphamide, its major active metabolites and the new oxazaphosphorine ASTA Z 7557 (INN mafosfamide) , 2004, Investigational New Drugs.
[51] M. Hung,et al. The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines , 2010, Breast cancer : basic and clinical research.
[52] R. Chen,et al. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance , 2009, Cell cycle.
[53] S. Wilhelm,et al. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. , 2006, Cancer research.
[54] Maria Vinci,et al. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation , 2012, BMC Biology.
[55] Marilena Loizidou,et al. 3D tumour models: novel in vitro approaches to cancer studies , 2011, Journal of Cell Communication and Signaling.
[56] W. Gerald,et al. Genes that mediate breast cancer metastasis to the brain , 2009, Nature.
[57] Alessandro Bevilacqua,et al. 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained , 2016, Scientific Reports.
[58] N. Ahmed,et al. Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research , 2013, Front. Oncol..
[59] Anne-Marie Mes-Masson,et al. Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC) , 2007, Molecular carcinogenesis.
[60] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[61] Genee Y. Lee,et al. The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression , 2007, Molecular oncology.
[62] Hwan-You Chang,et al. Recent advances in three‐dimensional multicellular spheroid culture for biomedical research , 2008, Biotechnology journal.
[63] W. Mueller‐Klieser. Three-dimensional cell cultures: from molecular mechanisms to clinical applications. , 1997, American journal of physiology. Cell physiology.
[64] C. Perou,et al. The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes , 2007, Clinical Cancer Research.
[65] Joshua M. Stuart,et al. Subtype and pathway specific responses to anticancer compounds in breast cancer , 2011, Proceedings of the National Academy of Sciences.
[66] S. Kaye,et al. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research , 2013, Nature Reviews Cancer.
[67] W. Mueller‐Klieser. Tumor biology and experimental therapeutics. , 2000, Critical reviews in oncology/hematology.
[68] Vítor M Gaspar,et al. 3D tumor spheroids: an overview on the tools and techniques used for their analysis. , 2016, Biotechnology advances.
[69] M. Platt,et al. Monocyte-derived macrophage assisted breast cancer cell invasion as a personalized, predictive metric to score metastatic risk , 2015, Scientific Reports.
[70] A. Skubitz,et al. Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. , 2001, The American journal of pathology.